"The Blue Book of the Development of China's Anti -prescription Pharmaceutical Industry" was released
Release time: 2011-06-03 & nbsp & nbsp & nbsp Source:
Business News Agency, May 27. The "Blue Book of the Development of the Chinese Anti-prescription Pharmaceutical Industry" compiled by the OTC Drug Association (2010) (2010) (2010) The 8th China Self-Medicine Annual Conference and the China UN Anti-prescription Drug Association held on May 25-27 Published to the society at the Third Member Conference of the Fifth Session。The compilation of "Blue Book" has received the attention of related industry associations、Support and SFDA Southern Medical Economics Institute's authoritative information and data support。
"Blue Book" focuses on the development history of China's non -prescription pharmaceutical industry，Analysis of the development status of the non -prescription pharmaceutical industry，Study problems encountered in the development of the non -prescription drug industry，Make suggestions to the government。At the same time, inspire enterprises My stake betting appto Stake Sports Bettingcontinue to create brands，Provide safety for consumers、Effective、Convenient、Drugs that are easy to obtain。
"Blue Book" is divided into two parts: text and attachment。The text part reviews the development process of China's OTC industry，Introduce the current status and variety classification and market conditions of the industry，Observation of future industry development，and put forward policies and regulations to the government department to adapt to the characteristics of over -the -counter drugs;、Some key non -prescription drug production distribution enterprises、The major category market analysis of non -prescription drugs and relevant international management regulations。
"Blue Book" pointed out: In 1999, China SDA released the "Administrative Measures for the Classification of Prescription Drugs and African Medicine"，Announced the first batch of non -prescription drug directory and non -prescription proprietary logo。As of 2004，China has announced 6 batches of non -prescription catalog，4,326 varieties included in the directory，Among them, 920 chemicals，3406 Chinese medicines。Since 2004，China begins to implement the registration and conversion evaluation of over -the -counter drugs，Establish a dynamic monitoring mechanism for prescription drugs and non -prescription drugs。So far，391 drugs converted from prescription drugs to over -the -counter medicine，Among them, 128 chemicals，263 Chinese medicines。At the same time，24 medicines that are not suitable for managing the non -prescription drug (13 chemicals、11 Chinese medicines) Turn into a prescription medicine。
From 2000 to the present，Ten years of the official implementation of drug classification management，stake sports betting appOTC Stake Sports Bettingmarket has rapid development。China's OTC market in 2000 is 25.3 billion yuan，By 2009 OTC market size has reached 120.95 billion yuan，increased by nearly 5 times。Where，2009 Chinese Hospital OTC market size was 48.71 billion yuan，The scale of the retail terminal market is 72.24 billion yuan，Retail terminal accounts for 60%of the entire OTC market size。With the rapid growth of my country's self -drug market，The importance of China's status in the world's self -treatment industry is increasingly apparent。As the spokesperson of the industry，China APIC Drug Association has actively participated in the global and intercontinental conferences such as WSMI in the World and Intercontinental Conference since joining the World Association (WSMI) in 1988，Especially the 16th conference of WSMI in 2008、2004 WSMI Sixth Asia -Pacific Conference in Beijing was successfully held，To promote the international exchanges of my country's self -medicine industry、Promoting the healthy development of the industry has played an important role。Recommended by the association，Vice President of China Anti -prescription Drug Association、Dr. Guo Zhenyu, Chairman and General Manager of Kunming Dianhong Pharmaceutical Co., Ltd.，Become the chairman of WSMI in November 2010，and will officially take office at the 17th Conference of WSMI in October 2011 in October 2011，Become the first Chinese chairman to lead the World Association。"Blue Book" at the same time，China's OTC market has developed rapidly in recent years，But there are still some gaps with the rapid development of the entire pharmaceutical industry，The main manifestation is: the drug classification management regulatory system needs to be improved，My stake betting appAbout Stake Sports BettingOTC registration and conversion，Name (tag、Manual) Management，Medical Insurance Pay、Price management regulations have not fully reflected the characteristics of non -prescription drugs，Different from prescription drugs，Not conducive to OTC's innovation and brand building and the healthy development of the industry。For this，OTC Association will propose to relevant departments to simplify the OTC registration and conversion process，Encourage OTC product innovation，Different from prescription drugs，Actively support and My stake betting appSupport the creation of an OTC brand，Research and Reform of the medical insurance payment policy of OTC drugs，Enterprise independent pricing policy for OTC varieties that implement market adjustment prices，The government priced OTC variety should fully reflect the value of the non -prescription drug brand，The government should pay more attention to and support self -care and responsible self -responsible self -care for the formulation of medical reform policies and the macro development planning planning of medical reform。
"Blue Book" pointed out: due to the improvement of people's health knowledge level and changes in the concept of health care，It is more willing to self -see the minor disease and the rehabilitation and prevention of self -judgment。Therefore, there is a broad prospect for the development of non -prescription drugs in China。It is expected to be from 2014，China's OTC market size will reach 192.3 billion yuan ($ 28.7 billion)。
"Blue Book" estimates，Government management department will gradually formulate a set of management regulations and technical regulations suitable for OTC characteristics。Including simplifying OTC access approval and conversion procedures，My stake betting appSupport stake sports betting appthe creation of OTC brand，Expand the indication range of OTC，Relax price management of certain OTC varieties。
"Blue Book" finally pointed out，The problems and suggestions on the blue book this time，will not be one、Solving all within two years。Writing and publishing the "Blue Book" aims to build a platform for industry communication with the government。The industry will continue to discuss related issues with the government，to reach a consensus，Gradual solution。China APIC Drug Association said，"Blue Book" will be released every two years in the future。
"Blue Book" focuses on the development history of China's non -prescription pharmaceutical industry，Analysis of the development status of the non -prescription pharmaceutical industry，Study problems encountered in the development of the non -prescription drug industry，Make suggestions to the government。At the same time, inspire enterprises My stake betting appto Stake Sports Bettingcontinue to create brands，Provide safety for consumers、Effective、Convenient、Drugs that are easy to obtain。
"Blue Book" is divided into two parts: text and attachment。The text part reviews the development process of China's OTC industry，Introduce the current status and variety classification and market conditions of the industry，Observation of future industry development，and put forward policies and regulations to the government department to adapt to the characteristics of over -the -counter drugs;、Some key non -prescription drug production distribution enterprises、The major category market analysis of non -prescription drugs and relevant international management regulations。
"Blue Book" pointed out: In 1999, China SDA released the "Administrative Measures for the Classification of Prescription Drugs and African Medicine"，Announced the first batch of non -prescription drug directory and non -prescription proprietary logo。As of 2004，China has announced 6 batches of non -prescription catalog，4,326 varieties included in the directory，Among them, 920 chemicals，3406 Chinese medicines。Since 2004，China begins to implement the registration and conversion evaluation of over -the -counter drugs，Establish a dynamic monitoring mechanism for prescription drugs and non -prescription drugs。So far，391 drugs converted from prescription drugs to over -the -counter medicine，Among them, 128 chemicals，263 Chinese medicines。At the same time，24 medicines that are not suitable for managing the non -prescription drug (13 chemicals、11 Chinese medicines) Turn into a prescription medicine。
From 2000 to the present，Ten years of the official implementation of drug classification management，stake sports betting appOTC Stake Sports Bettingmarket has rapid development。China's OTC market in 2000 is 25.3 billion yuan，By 2009 OTC market size has reached 120.95 billion yuan，increased by nearly 5 times。Where，2009 Chinese Hospital OTC market size was 48.71 billion yuan，The scale of the retail terminal market is 72.24 billion yuan，Retail terminal accounts for 60%of the entire OTC market size。With the rapid growth of my country's self -drug market，The importance of China's status in the world's self -treatment industry is increasingly apparent。As the spokesperson of the industry，China APIC Drug Association has actively participated in the global and intercontinental conferences such as WSMI in the World and Intercontinental Conference since joining the World Association (WSMI) in 1988，Especially the 16th conference of WSMI in 2008、2004 WSMI Sixth Asia -Pacific Conference in Beijing was successfully held，To promote the international exchanges of my country's self -medicine industry、Promoting the healthy development of the industry has played an important role。Recommended by the association，Vice President of China Anti -prescription Drug Association、Dr. Guo Zhenyu, Chairman and General Manager of Kunming Dianhong Pharmaceutical Co., Ltd.，Become the chairman of WSMI in November 2010，and will officially take office at the 17th Conference of WSMI in October 2011 in October 2011，Become the first Chinese chairman to lead the World Association。"Blue Book" at the same time，China's OTC market has developed rapidly in recent years，But there are still some gaps with the rapid development of the entire pharmaceutical industry，The main manifestation is: the drug classification management regulatory system needs to be improved，My stake betting appAbout Stake Sports BettingOTC registration and conversion，Name (tag、Manual) Management，Medical Insurance Pay、Price management regulations have not fully reflected the characteristics of non -prescription drugs，Different from prescription drugs，Not conducive to OTC's innovation and brand building and the healthy development of the industry。For this，OTC Association will propose to relevant departments to simplify the OTC registration and conversion process，Encourage OTC product innovation，Different from prescription drugs，Actively support and My stake betting appSupport the creation of an OTC brand，Research and Reform of the medical insurance payment policy of OTC drugs，Enterprise independent pricing policy for OTC varieties that implement market adjustment prices，The government priced OTC variety should fully reflect the value of the non -prescription drug brand，The government should pay more attention to and support self -care and responsible self -responsible self -care for the formulation of medical reform policies and the macro development planning planning of medical reform。
"Blue Book" pointed out: due to the improvement of people's health knowledge level and changes in the concept of health care，It is more willing to self -see the minor disease and the rehabilitation and prevention of self -judgment。Therefore, there is a broad prospect for the development of non -prescription drugs in China。It is expected to be from 2014，China's OTC market size will reach 192.3 billion yuan ($ 28.7 billion)。
"Blue Book" estimates，Government management department will gradually formulate a set of management regulations and technical regulations suitable for OTC characteristics。Including simplifying OTC access approval and conversion procedures，My stake betting appSupport stake sports betting appthe creation of OTC brand，Expand the indication range of OTC，Relax price management of certain OTC varieties。
"Blue Book" finally pointed out，The problems and suggestions on the blue book this time，will not be one、Solving all within two years。Writing and publishing the "Blue Book" aims to build a platform for industry communication with the government。The industry will continue to discuss related issues with the government，to reach a consensus，Gradual solution。China APIC Drug Association said，"Blue Book" will be released every two years in the future。
